SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-23-000077
Filing Date
2023-01-17
Accepted
2023-01-17 16:50:17
Documents
76
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 777959
7 lxrp_10qimg19.jpg GRAPHIC 1567
  Complete submission text file 0001640334-23-000077.txt   4336571

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20221130.xsd EX-101.SCH 50076
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20221130_lab.xml EX-101.LAB 247391
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20221130_cal.xml EX-101.CAL 44675
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20221130_pre.xml EX-101.PRE 208982
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20221130_def.xml EX-101.DEF 101944
70 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 802699
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 23532035
SIC: 2834 Pharmaceutical Preparations